Desktop Site |
09 Apr 21 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote  
Notices |
S&P BSE SENSEX 49,591.32 -154.89 -0.31 %
Corporate Announcement
  • Security Code500124
    CompanyDr Reddys Laboratories Ltd
    Exchange Disseminated Time
     
     
     Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets | 1/22/2015 3:46:15 PM 
     Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated January 21, 2015, titled "Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets". 
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(10H) 10 Apr 21|20:22 (IST)